C ytogenetic analysis of melanoma and nonmelanoma skin cancers has revealed recurrent aberrations, the frequency of which is reflective of malignant potential. Highly aberrant karyotypes are seen in melanoma, squamous cell carcinoma, solar keratosis and Merkel cell carcinoma with more stable karyotypes seen in basal cell carcinoma, keratoacanthoma, Bowens disease, dermatofibrosarcomaprotuberans and cutaneous lymphomas. Some aberrations were common amongst a number of skin cancer types including rearrangements and numerical abnormalities of chromosome 1, -3p, +3q, partial or entire trisomy 6, trisomy 7, +8q, -9p, +9q, partial or entire loss of chromosome 10, -17p, + 17q and partial or entire gain of chromosome 20. Combination of cytogenetic analysis with other molecular genetic techniques has enabled the identification of not only aberrant chromosomal regions, but also the genes that contribute to a maUgnant phenotype. This review provides a comprehensive summary of the pertinent cytogenetic aberrations associated with a variety of melanoma and nonmelanoma skin cancers.
Introduction
Skin cancer represents an accumulation of genetic abnormalities, inherent and/or sporadic, that alter the cells in such a way that normal function is impaired and a tumor arises. MaUgnant melanoma originates from aberrant melanocytes located in the basal (innermost) layer of the epidermis, whereas nonmelanoma skin cancer (NMSC) is due to abnormaUties of other cell types. The two most common forms of NMSC are basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), arising from keratinocytes in the basal and squamous (2nd innermost) layers, respectively.^ Other NMSCs include those developing from keratinocytes: solar keratosis (SK), SCC in situ (Bowens disease; BD) and keratoacanthoma (KA)^; and those arising from other cells within the skin or associated with the skin, such as: eccrine carcinomas, apocrine and sebaceous gland carcinomas, Kaposi sarcoma, liposarcoma, malignant fibrous histiocytoma, cutaneous lymphoma, Merkel cell carcinoma (MCC), extramammary Paget s disease, leiomyosarcoma, epitheUoid sarcoma, maUgnant schwannoma, maUgnant granular ceU tumor and dermatofibrosarcoma protuberans (DFSP).^ Although the development of both melanocytic and nonmelanocytic skin cancers is strongly reUant upon genetic factors, such as skin type, famiUal incidence (including inherited disorders), race and gender, it is also heavily influenced by environmental factors, most specificaUy ultraviolet (UV) radiation.^'^ UV radiation is known to induce DNA point mutations and smaU deletions.^'^ Also, Emri and coUeagues detected the formation of micronuclei, cytogenetic indicators of chromosomal damage, in melanocytes and fibroblasts exposed to UVB radiation and to a lesser extent Comparative genomic hybridization (CGH) and fluorescence in situ hybridization (FISH) are fluorescence based molecular tools used for the detection of molecular aberrations. CGH involves hybridization of differentially labeled tumor and reference DNA to normal metaphase spreads to globally screen for gross (>20 mb) copy number aberrations.^^ Imbalances are detected by changes in fluorescence values of the tumor DNA relative to the reference DNA and as such, it does not require the interpretation of complex tumor karyotypes or prior knowledge of aberrations for probe design.^^'^° Although CGH only reveals relatively large numerical or unbalanced aberrations, it identifies previously unknown DNA copy number changes of regions that may harbor tumor suppressor genes or oncogenes associated with cancer development. FISH also allows the identification of copy number changes, both large (up to whole chromosomes) and small (as low
